DOGS
Musculoskeletal disorders: Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg bodyweight (i.e. 0.4 mL/10 kg bodyweight). Wagg & Purr Meloxicam Dog Oral Suspension should be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg bodyweight, 24 hours after administration of the injection.
Reduction of post-operative pain:
Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg bodyweight (ie. 0.4 mL/10 kg bodyweight) before surgery, for example at the time of induction of anaesthesia
CATS
Reduction of post-operative pain: Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg bodyweight (ie. 0.06 mL/kg bodyweight) directly prior to induction of anaesthesia.
Management of febrile conditions:
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg bodyweight (ie. 0.06 mL/kg bodyweight).
Use the contents within 28 days of first broaching of the vial. Discard the unused portion.
Meloxicam 5 mg/mL
Dogs
-Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders
-Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery
Cats
-Reduction of pain after surgery
-Management of febrile conditions in combination with appropriate antibiotics
This product is contraindicated for use in pregnant or lactating animals.
This product is contraindicated for use in animals less than 6 weeks of age.
This product is contraindicated for use in animals suffering from gastrointestinal disorders such as irritation and hemorrhage, impaired hepatic, cardiac or renal function and hemorrhagic disorders, or where there is evidence of individual hypersensitivity to the product.
Before we can share our Therapeutic range, please confirm that you are a veterinarian.